In this cross-sectional, observational study, we investigated the association between antiplatelet therapy and cerebral microbleeds (CMBs) in community-based participants without stroke. The presence, count, and location of CMBs were evaluated by susceptibility weighted imaging. Antiplatelet therapy included aspirin use alone, clopidogrel use alone, cilostazol use alone, and dual antiplatelet therapy with aspirin and clopidogrel. We found that antiplatelet therapy was independently associated with CMBs at any location, particularly lobar CMBs, and aspirin use was a risk factor for any CMB and lobar CMBs. Our study suggests that optimizing antiplatelet treatment strategies in stroke-free population may decrease the risk of CMBs.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords